MELANOMAS

Clinical trials for MELANOMAS explained in plain language.

Never miss a new study

Get alerted when new MELANOMAS trials appear

Sign up with your email to follow new studies for MELANOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapy aims to boost immune attack on tough melanoma

Disease control Ongoing

This study tests a new drug, BI-1607, added to two existing immunotherapy drugs (ipilimumab and pembrolizumab) for people with advanced melanoma that has spread or can't be removed. The goal is to see if the combination is safe and helps the immune system fight cancer better. Abo…

Matched conditions: MELANOMAS

Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control

Last updated May 17, 2026 07:30 UTC

MELANOMAS

Get alerted when new MELANOMAS trials appear

New combo therapy aims to boost immune attack on tough melanoma